NCT04230720

Brief Summary

The purpose of this study is to determine if measurements for cataract surgery are improved with use of additional lubrication with artificial tears. The research study is being done to optimize measurements and provide patients with the best visual outcomes after cataract surgery.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Apr 2021

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 14, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 18, 2020

Completed
1.2 years until next milestone

Study Start

First participant enrolled

April 1, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

June 22, 2021

Status Verified

June 1, 2021

Enrollment Period

8 months

First QC Date

January 14, 2020

Last Update Submit

June 16, 2021

Conditions

Keywords

biometry measurementartificial tearcataract surgery

Outcome Measures

Primary Outcomes (2)

  • Change in Baseline in Keratometry Values (K1 and K2)

    The change in keratometry (K) values (K1 and K2) in all subjects

    Baseline, Day 14

  • Change in Baseline in Axis of Astigmatism

    The change in axis of astigmatism in all subjects

    Baseline, Day 14

Secondary Outcomes (3)

  • Change in Baseline Calculated Intraocular Lens Power

    Baseline, Day 14

  • Change in Keratometry Values (K1 and K2) in Ocular Surface Disease Subjects

    Baseline, Day 14

  • Change in Axis of Astigmatism in Ocular Surface Disease Subjects

    Baseline, Day 14

Study Arms (2)

Artificial Tears

EXPERIMENTAL

One eye of each participant is randomized to receive Systane Complete artificial tears 4 times a day for 14 days

Drug: Systane Complete

No Artificial Tears

NO INTERVENTION

One eye of each participant is randomized to receive no artificial tears for 14 days

Interventions

1 drop 4 times a day for 14 days

Artificial Tears

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female ≥ 18 years of age
  • Documentation of bilateral age-related senile cataracts diagnosis

You may not qualify if:

  • Patients currently using regularly scheduled artificial tears. Patients with infrequent or irregular use of artificial tears may not be excluded from the study.
  • Patients using contact lenses.
  • Patients with any other surface pathology affecting corneal biometric measurements determined with slit-lamp examination or medical history.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Weill Cornell Ophthalmology

New York, New York, 10021, United States

Location

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Study Officials

  • Ashley Brissette, MD

    Weill Medical College of Cornell University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 14, 2020

First Posted

January 18, 2020

Study Start

April 1, 2021

Primary Completion

December 1, 2021

Study Completion

December 1, 2021

Last Updated

June 22, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

Locations